Plexus Corp.'s SEC filings document operating results, financial condition, governance matters and material corporate events for its complex product design, manufacturing and services business. Recent 8-K reports furnish quarterly and fiscal-year earnings releases and related financial information for the company's product lifecycle operations across regulated end markets.
The filings also record shareholder meeting results, including director elections, advisory executive compensation votes and auditor ratification, as well as officer transition and compensation-arrangement disclosures. These records describe formal governance actions, executive roles and recurring public-company reporting obligations for PLXS.
PLEXUS CORP. (PLXS) announced a Board leadership transition. Dean A. Foate, Chair of the Board, will continue as a director and Chair until the conclusion of the 2027 Annual Meeting of Shareholders, when his Board service will end after he chose not to stand for reelection. The Board selected current director Michael V. Schrock to succeed him as Chair effective at the meeting’s conclusion, subject to Schrock’s reelection by shareholders. The Board also approved reducing its size from ten to nine directors, effective at that time. Foate’s decision is personal and is not the result of a disagreement with the Company, its management or the Board.
Plexus Corp. (PLXS), which designs, manufactures and services complex products, reported fiscal 2026 net sales of $4,964.957 million, up from $4,032.966 million in fiscal 2025. Fiscal 2026 included 53 weeks, versus 52 weeks in 2025. Net income rose to $202.490 million from $172.885 million, and diluted earnings per share were $7.41 versus $6.26.
Operating cash flow fell to $61.8 million from $249.2 million; free cash flow fell to $(28.9) million from $154.0 million, and is a non-GAAP measure. Plexus repurchased common stock for $85.0 million in fiscal 2026. A program authorizing up to $100.0 million became effective after completion of the prior program, with the full authority remaining as of October 3, 2026. Fiscal 2027 capital expenditures are estimated at approximately $175.0 million. One Industrial customer represented approximately 11% of fiscal 2026 sales; Industrial accounted for 44% of sales, Healthcare/Life Sciences 39%, and Aerospace/Defense 17%.
Plexus Corp. (PLXS) President & CEO Todd P. Kelsey filed a notice for a planned sale of 4,500 common shares, with an aggregate market value of $936,810 and an approximate sale date of November 18, 2026. The notice says the covered sales are being made pursuant to a trading plan adopted November 20, 2025. It also lists earlier sales by Kelsey: 1,500 shares for $376,467.45 on August 19, 2026; 1,500 shares for $363,615 on September 16, 2026; and 1,500 shares for $358,747.20 on October 26, 2026.
Plexus Corp. (PLXS) reported fiscal 2026 revenue of $4.965 billion, up 23% year over year, and GAAP diluted EPS of $7.41, versus $6.26 in fiscal 2025. Full-year GAAP operating margin was 5.3%; non-GAAP operating margin was 6.2% and non-GAAP diluted EPS was $8.97, excluding $1.56 of stock-based compensation expense. Fourth-quarter revenue was $1.427 billion, with GAAP diluted EPS of $2.51 and non-GAAP diluted EPS of $2.84.
For fiscal Q1 2027, Plexus guided to revenue of $1.410 billion to $1.460 billion and GAAP diluted EPS of $2.16 to $2.32; non-GAAP diluted EPS guidance is $2.46 to $2.62, excluding stock-based compensation expense. It set a new non-GAAP operating-margin goal of 6.5% to 7.0% and expects at least $100 million in fiscal 2027 free cash flow. Fiscal 2026 free cash flow was a $28.9 million usage: operating cash flow of $68.2 million less $97.1 million in capital expenditures. Plexus repurchased $85.0 million of shares during fiscal 2026, and its board approved a $100 million 2027 share repurchase program available to begin fiscal 2027.
Plexus Corp (PLXS) President & CEO Todd P. Kelsey sold 1,500 shares of common stock on October 21, 2026: 779 shares at a weighted average of $238.4691 per share and 721 shares at $239.9165 per share. Both sales were made pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.
Plexus Corp (PLXS) reports that President & CEO Todd P. Kelsey sold 1,500 shares of common stock on September 16, 2026 in a sale characterized as an open market or private transaction at $242.41 per share. Following this sale, he directly holds 64,388 shares. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on November 20, 2025.
PLEXUS CORP (PLXS) reported that Sr. VP & CFO David Westen Abuhl exercised Restricted Stock Units into common stock on September 15, 2026. He converted 2,500 Restricted Stock Units granted under the Plexus Corp. 2024 Omnibus Incentive Plan into 2,500 shares of common stock, with 800 shares delivered or withheld for payment of exercise price or tax liability. Following this vesting event, 5,000 Restricted Stock Units remain directly held.
The vested units represented one third of the original RSU grant and were structured so that each unit represented a contingent right to receive one share of Plexus Corp. common stock, in a grant that qualifies under Rule 16b-3. No Rule 10b5-1 trading plan is reported for these transactions.
Plexus Corp (PLXS) director Karen Marie Rapp reported selling 500 shares of common stock on August 31, 2026 in an open-market or private transaction at $240.87 per share. After this sale, she directly holds 7,535 shares of Plexus common stock. The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on February 6, 2026.
Plexus Corp. (PLXS) reports that its Board of Directors approved a new $100.0 million share repurchase program on August 20, 2026. This authorization will begin upon expiration of the company’s current $100.0 million repurchase program. As of August 19, 2026, the remaining balance under the current program was $9.6 million.
Plexus states it has no specific schedule or commitment for future repurchases and may buy back shares in amounts, at prices, and at times it deems appropriate, subject to market conditions, legal requirements, financing and other considerations.
PLEXUS CORP (PLXS) reported that President & CEO Todd P. Kelsey sold a total of 1,500 shares of common stock on August 19, 2026 in three open-market transactions. The sales were made at prices of $248.7887, $251.0850, and $252.2300 per share and were executed pursuant to a Rule 10b5-1 plan adopted on November 20, 2025. One transaction at $251.0850 per share reflects a weighted average sale price for trades executed in the range of $251.00 to $251.18 per share.